Pneumococcal pilus-1 tip adhesin protein RrgA (RrgA)

RrgA is the tip adhesin protein of the type 1 pilus in *Streptococcus pneumoniae*, encoded within pilus islet 1 (PI-1). It is a large (893 amino acid) surface protein with four domains, one adopting an integrin-like fold for binding to collagen and other host extracellular matrix components. RrgA mediates strong adhesion to human respiratory epithelial cells, facilitates colonization, and is necessary for optimal virulence. It interacts directly with host complement receptor 3 (CR3/MAC-1, CD11b/CD18), modulating immune responses and promoting bacterial evasion from phagocytosis. RrgA, together with RrgB and RrgC, forms the pneumococcal pilus—a structure implicated in bacterial invasion including crossing the blood-brain barrier. Antibodies against RrgA can neutralize its adhesive effects and are under investigation in vaccine development, representing a promising strategy for preventing pneumococcal disease. RrgA is present in 20–30% of clinical isolates, and its expression correlates with increased virulence and inflammatory response.

Other names

Pneumococcal surface protein A (note: this is frequently used for "PspA," a different surface antigen, so it is potentially misleading here; RrgA is a distinct protein)Pilus-1 tip adhesinStreptococcus pneumoniae pilus-1 RrgAS. pneumoniae RrgA

Antibody-mediated neutralization: Experimental or vaccine-elicited antibodies bind RrgA, blocking its interaction with host cells or ECM and promoting opsonization. Immunization: Pilus proteins, including RrgA, can induce protective immune responses, blocking colonization and infection